The new, fast-spreading variant led some countries to tighten controls again. But inside United StatesYes, President Joe Biden Not planning “Control the country”, His spokesman said, Zen BisakI.
Last week, Omigron was responsible for 73.2% of new cases detected To us, According to the Centers for Disease Control and Prevention. Biden is due to address a series of talks on Tuesday on his administration’s plans to tackle the new wave of epidemics facing the country.
Preliminary data suggest that Omigron, which was found in dozens of countries after its appearance in South Africa in November, may be more contagious and more resistant to vaccines, despite signs that it is no more severe than the delta variant.
On Monday, World Health Organization (WHO) Director Tetros Adanom Caprais called on countries to redouble their efforts to end the epidemic and call for the cancellation of New Year’s celebrations because “it is better to celebrate later than later, and regret later.” ”.
“2022 should be the year we end the epidemic”, he said.
Anxiety is growing
Fears of a virus outbreak hit markets hard and oil fell 5%, while major European exchanges traded at a loss in line with the Asian trend.
Considering the progress of the variation, the Netherlands entered a new prison, Paris and London canceled the New Year celebrations, and Germany planned to tighten health restrictions on the same dates, according to a plan discussed by the AFP.
According to officials, Omigran’s dominance in the EU could become a variant in mid – January.
For its part, the Israeli government banned travel to several European countries due to infection and danger To us It can also be banned as a target.
The World Economic Forum will be held in Davos, Switzerland from January 17-21. “Postponed”Their organizers said.
In Latin America, Colombia announced that it had detected the first three Omigron cases among travelers. To us And Spain.
Argentina’s Ministry of Health discovered five new cases of Covit-19 cases five times a month until it reached 5,337 infections on Monday, a new strain on the country in early December.
Due to fears that it could trigger the spread of omigran, the European Pharmaceuticals Agency (EMA) on Monday approved the anticoagulant vaccine from the US laboratory Novavox, which uses more classical technology compared to other drugs already approved.
The head of the European Commission, Ursula van der Leyen, said he believed the drug was in Brussels. “Be a strong encouragement to those who have not been vaccinated or have not yet been vaccinated.”
This is because Pfizer / Bioentech and Moderna vaccines, which dominate the global response to Govit-19, use pioneering messenger RNA technology, which has not yet been widely tested.
The novovax vaccine is thus the fifth “It is recommended in the European Union to prevent Covid-19 in people over 18 years of age”, The EMA stressed in a statement. Others include BioNTech / Pfizer, Moderna, AstraZeneca and Johnson & Johnson.
The European Union has already signed an agreement to purchase 200 million doses of two injectable vaccines.
Nova Vox claims that its vaccine was 90.4% effective in a broader North American trial, but acknowledges that it still exists. “Test” Its effectiveness against the Omigron variant.
All vaccines attack the body’s immune system against the corona virus, but in different ways.
The so-called protein subunit technology of Novavax has been used for decades to fight diseases such as hepatitis B and whooping cough. Like other vaccines, it does not need to be stored at very low temperatures.
As of Sunday, the epidemic had killed 5.34 million people worldwide, according to the AFP balance, made from official sources.